Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 1.21
VAR's Cash to Debt is ranked lower than
61% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. VAR: 1.21 )
Ranked among companies with meaningful Cash to Debt only.
VAR' s Cash to Debt Range Over the Past 10 Years
Min: 0.24  Med: 4.10 Max: N/A
Current: 1.21
Equity to Asset 0.44
VAR's Equity to Asset is ranked lower than
76% of the 298 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. VAR: 0.44 )
Ranked among companies with meaningful Equity to Asset only.
VAR' s Equity to Asset Range Over the Past 10 Years
Min: 0.32  Med: 0.53 Max: 0.6
Current: 0.44
0.32
0.6
Interest Coverage 55.57
VAR's Interest Coverage is ranked higher than
54% of the 192 Companies
in the Global Medical Devices industry.

( Industry Median: 45.13 vs. VAR: 55.57 )
Ranked among companies with meaningful Interest Coverage only.
VAR' s Interest Coverage Range Over the Past 10 Years
Min: 66.56  Med: 100.85 Max: 226.41
Current: 55.57
66.56
226.41
F-Score: 6
Z-Score: 4.07
M-Score: -2.26
WACC vs ROIC
6.23%
29.22%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 16.81
VAR's Operating margin (%) is ranked higher than
85% of the 305 Companies
in the Global Medical Devices industry.

( Industry Median: 2.61 vs. VAR: 16.81 )
Ranked among companies with meaningful Operating margin (%) only.
VAR' s Operating margin (%) Range Over the Past 10 Years
Min: 17.71  Med: 20.48 Max: 22.67
Current: 16.81
17.71
22.67
Net-margin (%) 12.77
VAR's Net-margin (%) is ranked higher than
83% of the 305 Companies
in the Global Medical Devices industry.

( Industry Median: 0.86 vs. VAR: 12.77 )
Ranked among companies with meaningful Net-margin (%) only.
VAR' s Net-margin (%) Range Over the Past 10 Years
Min: 13.24  Med: 14.65 Max: 15.36
Current: 12.77
13.24
15.36
ROE (%) 23.61
VAR's ROE (%) is ranked higher than
93% of the 299 Companies
in the Global Medical Devices industry.

( Industry Median: 0.98 vs. VAR: 23.61 )
Ranked among companies with meaningful ROE (%) only.
VAR' s ROE (%) Range Over the Past 10 Years
Min: 24.24  Med: 28.73 Max: 33.66
Current: 23.61
24.24
33.66
ROA (%) 10.95
VAR's ROA (%) is ranked higher than
88% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: -0.34 vs. VAR: 10.95 )
Ranked among companies with meaningful ROA (%) only.
VAR' s ROA (%) Range Over the Past 10 Years
Min: 11.83  Med: 15.13 Max: 17.33
Current: 10.95
11.83
17.33
ROC (Joel Greenblatt) (%) 61.93
VAR's ROC (Joel Greenblatt) (%) is ranked higher than
92% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 4.07 vs. VAR: 61.93 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
VAR' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 70.35  Med: 96.68 Max: 130.37
Current: 61.93
70.35
130.37
Revenue Growth (3Y)(%) 7.60
VAR's Revenue Growth (3Y)(%) is ranked higher than
67% of the 234 Companies
in the Global Medical Devices industry.

( Industry Median: 3.70 vs. VAR: 7.60 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
VAR' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -27.1  Med: 11.80 Max: 17.4
Current: 7.6
-27.1
17.4
EBITDA Growth (3Y)(%) 2.60
VAR's EBITDA Growth (3Y)(%) is ranked higher than
52% of the 199 Companies
in the Global Medical Devices industry.

( Industry Median: 1.90 vs. VAR: 2.60 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
VAR' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -47.6  Med: 13.90 Max: 65.2
Current: 2.6
-47.6
65.2
EPS Growth (3Y)(%) 2.90
VAR's EPS Growth (3Y)(%) is ranked higher than
51% of the 201 Companies
in the Global Medical Devices industry.

( Industry Median: 2.60 vs. VAR: 2.90 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
VAR' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -58.5  Med: 14.20 Max: 113.8
Current: 2.9
-58.5
113.8
» VAR's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-07-29)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

VAR Guru Trades in Q2 2015

Ray Dalio 129,674 sh (+1201.82%)
Paul Tudor Jones 11,796 sh (+336.89%)
John Hussman 150,000 sh (+20.00%)
David Rolfe 2,307,861 sh (+7.45%)
First Pacific Advisors 124,700 sh (unchged)
Westport Asset Management 277,500 sh (unchged)
Jim Simons Sold Out
Charles Brandes 132,527 sh (-0.60%)
Jeremy Grantham 185,124 sh (-18.02%)
Joel Greenblatt 8,407 sh (-91.60%)
» More
Q3 2015

VAR Guru Trades in Q3 2015

Jim Simons 284,800 sh (New)
First Eagle Investment 153,130 sh (New)
Joel Greenblatt 500,631 sh (+5854.93%)
Paul Tudor Jones 21,756 sh (+84.44%)
Charles Brandes 135,215 sh (+2.03%)
CI Can Am Small Cap 58,925 sh (unchged)
Westport Asset Management 277,500 sh (unchged)
Ray Dalio Sold Out
David Rolfe 1,945,422 sh (-15.70%)
First Pacific Advisors 84,400 sh (-32.32%)
John Hussman 50,000 sh (-66.67%)
Jeremy Grantham 18,616 sh (-89.94%)
» More
Q4 2015

VAR Guru Trades in Q4 2015

George Soros 6,000 sh (New)
Ray Dalio 49,756 sh (New)
First Eagle Investment 1,305,609 sh (+752.61%)
Charles Brandes 181,830 sh (+34.47%)
Westport Asset Management 277,500 sh (unchged)
First Pacific Advisors Sold Out
John Hussman Sold Out
Jim Simons 195,200 sh (-31.46%)
Paul Tudor Jones 6,138 sh (-71.79%)
Jeremy Grantham 3,850 sh (-79.32%)
David Rolfe 31,700 sh (-98.37%)
Joel Greenblatt 5,962 sh (-98.81%)
» More
Q1 2016

VAR Guru Trades in Q1 2016

Leucadia National 3,900 sh (New)
Joel Greenblatt 253,227 sh (+4147.35%)
First Eagle Investment 3,197,123 sh (+144.88%)
Ray Dalio 106,243 sh (+113.53%)
Jeremy Grantham Sold Out
Paul Tudor Jones Sold Out
George Soros Sold Out
Charles Brandes 177,421 sh (-2.42%)
Westport Asset Management 255,300 sh (-8.00%)
Jim Simons 83,382 sh (-57.28%)
David Rolfe 5,075 sh (-83.99%)
» More
» Details

Insider Trades

Latest Guru Trades with VAR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices
Compare:NYSE:TFX, OTCPK:SONVY, NAS:ALGN, OTCPK:SDMHF, OTCPK:WILYY, OTCPK:CHEOY, NAS:ABMD, OTCPK:FSPKF, NAS:NUVA, NAS:IART, OTCPK:EKTAY, OTCPK:GGNDF, NAS:MASI, OTCPK:SHWGF, NAS:LIVN, OTCPK:NHNKY, NYSE:GMED, NYSE:NVRO, NYSE:PEN, NAS:WMGI » details
Traded in other countries:VNM.Germany,
Varian Medical Systems Inc manufactures medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Varian Medical Systems Inc is a Delaware corporation originally incorporated in the year 1948 as Varian Associates, Inc. The Company manufactures medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. It is a supplier of x-ray imaging components for medical, scientific, and industrial applications and also supplies x-ray imaging products for cargo screening and industrial inspection. The Company has two reportable operating segments: Oncology Systems and X-ray Products. The Oncology Systems business segment designs, manufactures, sells and services hardware and software products for treating cancer with radiotherapy, stereotactic radiotherapy, stereotactic body radiotherapy, stereotactic radiosurgery and brachytherapy. Products include linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment and accessories; as well as information management, treatment planning and image processing software. Oncology Systems products enable radiation oncology departments in hospitals and clinics to perform conventional radiotherapy treatments and offer treatments such as fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy and stereotactic radiotherapy, as well as to treat patients using brachytherapy techniques, which involve temporarily implanting radioactive sources. The Company's Oncology Systems products are also used by neurosurgeons to perform stereotactic radiosurgery. Oncology Systems customers include university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices and cancer care clinics. The X-ray Products business segment designs, manufactures, sells and services x-ray imaging components for use in a range of applications, including radiographic or fluoroscopic imaging, mammography, special procedures, computed tomography and industrial applications. The Company's x-ray imaging components are sold to large imaging system OEM customers that incorporate them into their medical diagnostic, dental, veterinary and industrial imaging systems. It sells x-ray tubes and flat panel digital image detectors for filmless x-ray imaging to small OEMs, independent service companies and directly to end-users for replacement purposes. The Company has three other businesses that are reported together under the Other category. The Company's imaging components business designs, manufactures, sells and services Linatron x-ray accelerators, imaging processing software and image detection products for security and inspection purposes, such as cargo screening at ports and borders and nondestructive examination in a variety of applications. The VPT business develops, designs, manufactures, sells and services products and systems for delivering proton therapy, a form of external beam radiotherapy using proton be

Guru Investment Theses on Varian Medical Systems Inc

Wedgewood Partners Comments on Varian Medical Systems - Jan 18, 2016

We sold Varian Medical Systems (NYSE:VAR) early in the quarter. The Company maintains its position as the dominant supplier of radiotherapy equipment and software, worldwide. We see Varian’s core business growing earnings per share at a steady, low to mid-single digit rate, as developed markets have reached maturity. In addition, the dramatic devaluation of the Japanese yen relative to the U.S. Dollar has caused some competitive pressures in its non-core Imaging and Components segment, further pressuring growth. While Imaging Components might regain competitiveness over the next few years, we do not think it will be enough to drive earnings growth to our required rate.



From Wedgewood Partners' fourth quarter 2015 client letter.



Check out David Rolfe latest stock trades

Top Ranked Articles about Varian Medical Systems Inc

Wedgewood Partners Comments on Varian Medical Systems Guru stock highlight
We sold Varian Medical Systems (NYSE:VAR) early in the quarter. The Company maintains its position as the dominant supplier of radiotherapy equipment and software, worldwide. We see Varian’s core business growing earnings per share at a steady, low to mid-single digit rate, as developed markets have reached maturity. In addition, the dramatic devaluation of the Japanese yen relative to the U.S. Dollar has caused some competitive pressures in its non-core Imaging and Components segment, further pressuring growth. While Imaging Components might regain competitiveness over the next few years, we do not think it will be enough to drive earnings growth to our required rate. Read more...
David Rolfe Trims Holdings in Alphabet, Visa in 3rd Quarter A look at Wedgewood Partners' largest sales
Wedgewood Partners Inc. was founded in 1988 with the goal of providing investors with a superior approach to managing investment portfolios. David Rolfe (Trades, Portfolio) has been Wedgewood's CIO for 18 years. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 19.56
VAR's P/E(ttm) is ranked higher than
67% of the 168 Companies
in the Global Medical Devices industry.

( Industry Median: 26.63 vs. VAR: 19.56 )
Ranked among companies with meaningful P/E(ttm) only.
VAR' s P/E(ttm) Range Over the Past 10 Years
Min: 12.14  Med: 20.61 Max: 40.92
Current: 19.56
12.14
40.92
Forward P/E 15.90
VAR's Forward P/E is ranked higher than
87% of the 54 Companies
in the Global Medical Devices industry.

( Industry Median: 24.15 vs. VAR: 15.90 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 19.56
VAR's PE(NRI) is ranked higher than
67% of the 168 Companies
in the Global Medical Devices industry.

( Industry Median: 26.92 vs. VAR: 19.56 )
Ranked among companies with meaningful PE(NRI) only.
VAR' s PE(NRI) Range Over the Past 10 Years
Min: 11.14  Med: 20.54 Max: 40.86
Current: 19.56
11.14
40.86
Price/Owner Earnings (ttm) 22.56
VAR's Price/Owner Earnings (ttm) is ranked higher than
62% of the 108 Companies
in the Global Medical Devices industry.

( Industry Median: 31.00 vs. VAR: 22.56 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
VAR' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 15.7  Med: 23.89 Max: 55.88
Current: 22.56
15.7
55.88
P/B 4.44
VAR's P/B is ranked lower than
68% of the 297 Companies
in the Global Medical Devices industry.

( Industry Median: 2.74 vs. VAR: 4.44 )
Ranked among companies with meaningful P/B only.
VAR' s P/B Range Over the Past 10 Years
Min: 3.06  Med: 5.12 Max: 11.35
Current: 4.44
3.06
11.35
P/S 2.52
VAR's P/S is ranked higher than
55% of the 287 Companies
in the Global Medical Devices industry.

( Industry Median: 2.99 vs. VAR: 2.52 )
Ranked among companies with meaningful P/S only.
VAR' s P/S Range Over the Past 10 Years
Min: 1.62  Med: 2.95 Max: 5.97
Current: 2.52
1.62
5.97
PFCF 22.84
VAR's PFCF is ranked higher than
60% of the 95 Companies
in the Global Medical Devices industry.

( Industry Median: 29.37 vs. VAR: 22.84 )
Ranked among companies with meaningful PFCF only.
VAR' s PFCF Range Over the Past 10 Years
Min: 14.53  Med: 22.38 Max: 48.02
Current: 22.84
14.53
48.02
POCF 17.67
VAR's POCF is ranked higher than
53% of the 130 Companies
in the Global Medical Devices industry.

( Industry Median: 19.79 vs. VAR: 17.67 )
Ranked among companies with meaningful POCF only.
VAR' s POCF Range Over the Past 10 Years
Min: 11.52  Med: 17.90 Max: 37.81
Current: 17.67
11.52
37.81
EV-to-EBIT 13.67
VAR's EV-to-EBIT is ranked higher than
70% of the 167 Companies
in the Global Medical Devices industry.

( Industry Median: 20.28 vs. VAR: 13.67 )
Ranked among companies with meaningful EV-to-EBIT only.
VAR' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.8  Med: 13.60 Max: 25.8
Current: 13.67
6.8
25.8
EV-to-EBITDA 12.02
VAR's EV-to-EBITDA is ranked higher than
62% of the 177 Companies
in the Global Medical Devices industry.

( Industry Median: 17.82 vs. VAR: 12.02 )
Ranked among companies with meaningful EV-to-EBITDA only.
VAR' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.3  Med: 12.30 Max: 23.6
Current: 12.02
6.3
23.6
PEG 3.67
VAR's PEG is ranked lower than
53% of the 74 Companies
in the Global Medical Devices industry.

( Industry Median: 3.22 vs. VAR: 3.67 )
Ranked among companies with meaningful PEG only.
VAR' s PEG Range Over the Past 10 Years
Min: 0.76  Med: 1.30 Max: 5.25
Current: 3.67
0.76
5.25
Shiller P/E 23.53
VAR's Shiller P/E is ranked higher than
80% of the 44 Companies
in the Global Medical Devices industry.

( Industry Median: 40.52 vs. VAR: 23.53 )
Ranked among companies with meaningful Shiller P/E only.
VAR' s Shiller P/E Range Over the Past 10 Years
Min: 21.83  Med: 28.82 Max: 48.49
Current: 23.53
21.83
48.49
Current Ratio 1.64
VAR's Current Ratio is ranked lower than
77% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 2.88 vs. VAR: 1.64 )
Ranked among companies with meaningful Current Ratio only.
VAR' s Current Ratio Range Over the Past 10 Years
Min: 1.38  Med: 1.88 Max: 2.33
Current: 1.64
1.38
2.33
Quick Ratio 1.25
VAR's Quick Ratio is ranked lower than
72% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 2.09 vs. VAR: 1.25 )
Ranked among companies with meaningful Quick Ratio only.
VAR' s Quick Ratio Range Over the Past 10 Years
Min: 1.04  Med: 1.49 Max: 1.87
Current: 1.25
1.04
1.87
Days Inventory 124.60
VAR's Days Inventory is ranked higher than
54% of the 282 Companies
in the Global Medical Devices industry.

( Industry Median: 136.99 vs. VAR: 124.60 )
Ranked among companies with meaningful Days Inventory only.
VAR' s Days Inventory Range Over the Past 10 Years
Min: 69.24  Med: 95.37 Max: 119.05
Current: 124.6
69.24
119.05
Days Sales Outstanding 99.82
VAR's Days Sales Outstanding is ranked lower than
73% of the 271 Companies
in the Global Medical Devices industry.

( Industry Median: 68.67 vs. VAR: 99.82 )
Ranked among companies with meaningful Days Sales Outstanding only.
VAR' s Days Sales Outstanding Range Over the Past 10 Years
Min: 85.76  Med: 90.38 Max: 107.78
Current: 99.82
85.76
107.78
Days Payable 34.22
VAR's Days Payable is ranked lower than
77% of the 264 Companies
in the Global Medical Devices industry.

( Industry Median: 61.70 vs. VAR: 34.22 )
Ranked among companies with meaningful Days Payable only.
VAR' s Days Payable Range Over the Past 10 Years
Min: 30.46  Med: 36.26 Max: 41.88
Current: 34.22
30.46
41.88

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 12.49
VAR's Price/Net Current Asset Value is ranked lower than
76% of the 205 Companies
in the Global Medical Devices industry.

( Industry Median: 6.53 vs. VAR: 12.49 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
VAR' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 7.37  Med: 12.29 Max: 45.07
Current: 12.49
7.37
45.07
Price/Tangible Book 5.31
VAR's Price/Tangible Book is ranked lower than
62% of the 268 Companies
in the Global Medical Devices industry.

( Industry Median: 3.76 vs. VAR: 5.31 )
Ranked among companies with meaningful Price/Tangible Book only.
VAR' s Price/Tangible Book Range Over the Past 10 Years
Min: 3.62  Med: 6.56 Max: 11.91
Current: 5.31
3.62
11.91
Price/Projected FCF 1.32
VAR's Price/Projected FCF is ranked higher than
72% of the 126 Companies
in the Global Medical Devices industry.

( Industry Median: 2.06 vs. VAR: 1.32 )
Ranked among companies with meaningful Price/Projected FCF only.
VAR' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.95  Med: 1.48 Max: 4.43
Current: 1.32
0.95
4.43
Price/DCF (Earnings Based) 1.22
VAR's Price/DCF (Earnings Based) is ranked higher than
83% of the 18 Companies
in the Global Medical Devices industry.

( Industry Median: 1.91 vs. VAR: 1.22 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 0.84
VAR's Price/Median PS Value is ranked higher than
64% of the 268 Companies
in the Global Medical Devices industry.

( Industry Median: 1.02 vs. VAR: 0.84 )
Ranked among companies with meaningful Price/Median PS Value only.
VAR' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.6  Med: 1.06 Max: 3.54
Current: 0.84
0.6
3.54
Price/Graham Number 2.13
VAR's Price/Graham Number is ranked higher than
50% of the 137 Companies
in the Global Medical Devices industry.

( Industry Median: 2.06 vs. VAR: 2.13 )
Ranked among companies with meaningful Price/Graham Number only.
VAR' s Price/Graham Number Range Over the Past 10 Years
Min: 0.74  Med: 2.63 Max: 4.57
Current: 2.13
0.74
4.57
Earnings Yield (Greenblatt) (%) 7.30
VAR's Earnings Yield (Greenblatt) (%) is ranked higher than
84% of the 308 Companies
in the Global Medical Devices industry.

( Industry Median: 0.90 vs. VAR: 7.30 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
VAR' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 3.9  Med: 7.40 Max: 14.7
Current: 7.3
3.9
14.7
Forward Rate of Return (Yacktman) (%) 8.16
VAR's Forward Rate of Return (Yacktman) (%) is ranked higher than
55% of the 115 Companies
in the Global Medical Devices industry.

( Industry Median: 7.22 vs. VAR: 8.16 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
VAR' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 7.9  Med: 19.20 Max: 29.4
Current: 8.16
7.9
29.4

More Statistics

Revenue (TTM) (Mil) $3,118
EPS (TTM) $ 4.05
Beta0.64
Short Percentage of Float9.02%
52-Week Range $71.07 - 90.78
Shares Outstanding (Mil)95.21

Analyst Estimate

Sep16 Sep17 Sep18
Revenue (Mil $) 3,200 3,335 3,459
EPS ($) 4.48 4.93 5.25
EPS w/o NRI ($) 4.48 4.93 5.25
EPS Growth Rate
(3Y to 5Y Estimate)
8.04%
» More Articles for VAR

Headlines

Articles On GuruFocus.com
First Eagle Investment Boosts Stake in American Express May 06 2016 
7 High Quality Guru Stocks Apr 11 2016 
David Rolfe Sells More Than 98% of 4 Stakes in His Portfolio Mar 10 2016 
David Rolfe Sells Coach, Alphabet Mar 09 2016 
Wedgewood Partners Comments on Varian Medical Systems Jan 18 2016 
Wedgewood Partners 4th Quarter Client Letter: 'Back to Our Regularly Scheduled Stock Market' Jan 15 2016 
David Rolfe Trims Holdings in Alphabet, Visa in 3rd Quarter Nov 24 2015 
The Best Companies of the Medical Industry – September 2015 Sep 25 2015 
Wedgewood Partners 2nd Quarter 2015 Client Letter - Wedgewood On Sale Jul 20 2015 
Reversing a Declining Pattern in Earnings Per Share Feb 24 2015 

More From Other Websites
Varian Medical Systems, Inc. breached its 50 day moving average in a Bearish Manner : VAR-US : June... Jun 27 2016
Varian Medical Systems Holding Investor Meeting Today Jun 21 2016
Varian Medical Systems Holding Investor Meeting Today Jun 21 2016
Varian Medical Systems Launches Proton Therapy Blog Jun 20 2016
Varian Medical Systems Launches Proton Therapy Blog Jun 20 2016
Varian Medical Systems, Inc. – Value Analysis (NYSE:VAR) : June 17, 2016 Jun 17 2016
Varian Medical Clinches TrueBeam System Order in Australia Jun 17 2016
Icon Group in Australia Selects Varian Advanced Radiotherapy Equipment Jun 16 2016
Varian Medical Systems, Inc. breached its 50 day moving average in a Bearish Manner : VAR-US : June... Jun 16 2016
Icon Group in Australia Selects Varian Advanced Radiotherapy Equipment Jun 16 2016
How Are IHI’s Holdings’ Moving Averages Trending? Jun 14 2016
Varian and Russian Proton Therapy Center Achieve Milestone with Cyclotron Installation Jun 09 2016
Varian and Russian Proton Therapy Center Achieve Milestone with Cyclotron Installation Jun 09 2016
Varian Keeps Up the Winning Streak in Turkey, Expands Base Jun 08 2016
Varian to Showcase Imaging Solutions At 19th World Conference On Non-destructive Testing Jun 08 2016
Varian to Showcase Imaging Solutions At 19th World Conference On Non-destructive Testing Jun 08 2016
Varian Extending Advanced Cancer Care in Turkey Jun 07 2016
Varian Extending Advanced Cancer Care in Turkey Jun 07 2016
Hospital Outlays On High-Tech Equipment Trend Higher May 27 2016
Varian Spinoff Could Boost Sluggish Topline Growth, Says Analyst May 24 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)